Malaria News and Research

Latest Malaria News and Research

Despite limitations of global fund programs, dangers of cutting funding are worse

In this Financial Times opinion piece, journalist Andrew Jack examines how, "[a]fter a period of fast expansion, and strong progress in tackling AIDS, [tuberculosis (TB)] and malaria alike," the Global Fund to Fight AIDS, Tuberculosis and Malaria "has become a target in the era of austerity.

29 Nov 2011

New creative uses of DNA 'barcoding'

The newfound scientific power to quickly "fingerprint" species via DNA is being deployed to unmask quack herbal medicines, reveal types of ancient Arctic life frozen in permafrost, expose what eats what in nature, and halt agricultural and forestry pests at borders, among other applications across a wide array of public interests.

28 Nov 2011

Funds for AIDS, tuberculosis and malaria dry up

A global fund organization against three killer diseases says it has run out of money to pay for new grant programs for the next two years. An official with the Global Fund to Fight AIDS, Tuberculosis and Malaria said Thursday that it has been forced to cease giving new grants until 2014 because of global economic woes brought on by debt crises in the U.S. and Europe.

27 Nov 2011

Malaria is almost under control in Suriname

Malaria is almost under control in Suriname. According to an impact study conducted by Hélène Hiwat - van Laar, who was awarded a PhD on the subject on 21 November at Wageningen University, a five-year control programme with new strategies has proved successful. The people most at risk nowadays are the mobile gold miner communities, especially those along the French Guianese border.

24 Nov 2011

Guardian International Development Journalism Competition results posted

The Guardian this week posted the results of its 2011 International Development Journalism Competition. "Sixteen finalists -- eight amateur, eight professional -- were sent to the developing world to write a feature on a theme suggested by the non-governmental organization that hosted their trip," the newspaper notes.

24 Nov 2011

Panel discussion highlights USAID achievements on 50Th anniversary

This post in the Malaria Policy Center blog summarizes a panel discussion, titled "Partnerships for Global Health Success: Spotlight on USAID," that took place Monday in Washington, D.C., and was sponsored by Research!America.

23 Nov 2011

Potential cuts to global health spending threaten vision of 'AIDS-free generation'

The vision of an "AIDS-free generation" presented in a speech earlier this month by Secretary of State Hillary Rodham Clinton "is under threat in Congress," as "the House and the Senate are discussing significant cuts to the 2012 Obama administration request for global health funding," Jeanie Yoon, a physician with Doctors Without Borders/Medecins Sans Frontieres (MSF), writes in a Baltimore Sun opinion piece.

22 Nov 2011

Selecta commences SEL-068 Phase 1 clinical trial for smoking cessation and relapse prevention

Selecta Biosciences, Inc., a biopharmaceutical company developing a new class of synthetic vaccines and immunotherapies, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacodynamic profile of SEL-068, a nicotine vaccine candidate for smoking cessation and relapse prevention.

21 Nov 2011

Three 'critical issues' for Global Fund to consider to ensure 'further success'

While the recent report from a High-Level Independent Review Panel of the Global Fund to Fight AIDS, Tuberculosis and Malaria, "and the corresponding decisions of the Board, mark an important step towards the necessary improvements the Global Fund must make to fulfill its vital mandate in the coming decade and beyond," "the report does not provide direction or solutions on certain critical issues that will define the further success and impact of the Global Fund," Richard Feachem, founding executive director of the Global Fund, writes in a Lancet commentary.

19 Nov 2011

Cuts to U.S. global health spending would mean 'stark future' for millions

Disregarding advances "that have the potential to significantly reduce the death toll from HIV/AIDS, malaria, malnutrition, and other insidious killers, ... both the House and the Senate are pushing significant cuts to the 2012 Obama request for global health funding," Matthew Spitzer, president of the U.S. section of Doctors Without Borders/Medecins Sans Frontieres, writes in an opinion piece on the Huffington Post's "Impact" blog.

19 Nov 2011

U.S., U.N. food agencies downgrade three Somalia famine zones to emergency status

U.S. and U.N. food agencies on Friday said three famine zones in Somalia had been downgraded to emergency status, as aid had reduced death rates, but "three other areas -- including the refugee communities of Somalia's capital, Mogadishu -- remain in the famine zone," the Associated Press/CBSNews reports.

19 Nov 2011

Scientists solve mystery behind why people with defective hemoglobin do not contract malaria

Why do people with a hereditary mutation of the red blood pigment hemoglobin not contract severe malaria? Scientists in the group headed by Prof. Michael Lanzer of the Department of Infectious Diseases at Heidelberg University Hospital have now solved this mystery.

19 Nov 2011

New class of malaria drugs could be used as both prevention, treatment, study shows

"A group of researchers led by Novartis AG have discovered novel malaria compounds that may prove to be more efficient than currently available treatments and could be used as a prophylactic," the Wall Street Journal reports.

19 Nov 2011

Sony Corporation, Global Fund enter into partnership to implement behavior change projects

"Sony Corporation and the Global Fund to Fight AIDS, Tuberculosis and Malaria have entered into a partnership for the implementation of behavior change projects, in which Sony provides state of the art equipment and movies and the Global Fund ensures it gets to agencies best able to reach communities most in need," a Global Fund press release states, noting, "This partnership is the first pilot case that combines pro bono and in-kind contribution."

19 Nov 2011

Aid targeting high mortality diseases 'lays the groundwork' for improving primary health care services

"In recent years, initiatives such as the President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria have helped rein in some of the biggest scourges," Paul Farmer, co-founder of Partners in Health and chair of the Department of Global Health and Social Medicine at Harvard Medical School, writes in a Washington Post opinion piece.

19 Nov 2011

Inovio announces results from SynCon avian influenza vaccine Phase I study

Inovio Pharmaceuticals, Inc., which is advancing synthetic vaccines to fight cancers and infectious diseases, announced today that a single intradermal (ID) electroporation boost of its SynCon avian influenza vaccine generated HAI titers against six different, unmatched strains of H5N1 - a distinct new clinical achievement on the global research community's path to develop universal influenza vaccines.

18 Nov 2011

NewYork-Presbyterian/Columbia opens Center for Acute Respiratory Failure

NewYork-Presbyterian Hospital/Columbia University Medical Center has officially opened the Center for Acute Respiratory Failure, which offers, among other services, expertise in using lung bypass technology to help adult patients whose lungs are rapidly shutting down.

18 Nov 2011

Researchers discover new class of antimalarial compounds

Researchers have discovered a group of chemical compounds that might one day be developed into drugs that can treat malaria infection in both the liver and the bloodstream.

18 Nov 2011

Report by aid watchdog group finds many international donors lack transparency

IRIN examines the results of a report by the aid watchdog group Publish What You Fund that examines "whether donors publish information about their budgets, their allocation and procurement policies, or audit reports on their own performance" and "finds that most international aid donors are still not open enough about their aid programs, and some offer no information at all."

18 Nov 2011

HuffPost Green examines relationship between environment, malaria

As part of its series on the relationships between human, animal and environmental health, titled "The Infection Loop," HuffPost Green examines how changes in climate and landscape, human movement, agricultural practices, and microbe adaptation are affecting the spread of malaria.

18 Nov 2011

Malaria News and Research

Latest Malaria News and Research

Despite limitations of global fund programs, dangers of cutting funding are worse

New creative uses of DNA 'barcoding'

Funds for AIDS, tuberculosis and malaria dry up

Malaria is almost under control in Suriname

Guardian International Development Journalism Competition results posted

Panel discussion highlights USAID achievements on 50Th anniversary

Potential cuts to global health spending threaten vision of 'AIDS-free generation'

Selecta commences SEL-068 Phase 1 clinical trial for smoking cessation and relapse prevention

Three 'critical issues' for Global Fund to consider to ensure 'further success'

Cuts to U.S. global health spending would mean 'stark future' for millions

U.S., U.N. food agencies downgrade three Somalia famine zones to emergency status

Scientists solve mystery behind why people with defective hemoglobin do not contract malaria

New class of malaria drugs could be used as both prevention, treatment, study shows

Sony Corporation, Global Fund enter into partnership to implement behavior change projects

Aid targeting high mortality diseases 'lays the groundwork' for improving primary health care services

Inovio announces results from SynCon avian influenza vaccine Phase I study

NewYork-Presbyterian/Columbia opens Center for Acute Respiratory Failure

Researchers discover new class of antimalarial compounds

Report by aid watchdog group finds many international donors lack transparency

HuffPost Green examines relationship between environment, malaria

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in